Aspergillus flavus infection of an aortic bypass.
Marroni
M
M
Department of Experimental Medicine and Biochemical Science, University of Perugia, Italy. massimo.marroni@libero.it
Cao
P
P
Repetto
A
A
Prattichizzo
L
L
Parlani
G
G
Fiorio
M
M
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001012:Aorta, Abdominal; D001228:Aspergillosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D001231:Aspergillus flavus / Q000302:isolation & purification* / Q000472:pathogenicity; D001807:Blood Vessel Prosthesis / Q000009:adverse effects* / Q000382:microbiology; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000209:etiology; D016459:Prosthesis-Related Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D012086:Reoperation; D012772:Shock, Septic / Q000209:etiology; D013997:Time Factors
D000935:Antifungal Agents; D000666:Amphotericin B